Human medicines European public assessment report (EPAR): Levetiracetam Sun, levetiracetam, Date of authorisation: 14/12/2011, Revision: 22, Status: Authorised

Human medicines European public assessment report (EPAR): Levetiracetam Sun, levetiracetam, Date of authorisation: 14/12/2011, Revision: 22, Status: Authorised

Human medicines European public assessment report (EPAR): Jalra, vildagliptin, Date of authorisation: 19/11/2008, Revision: 26, Status: Authorised

Human medicines European public assessment report (EPAR): Jalra, vildagliptin, Date of authorisation: 19/11/2008, Revision: 26, Status: Authorised

Human medicines European public assessment report (EPAR): Telzir, fosamprenavir, Date of authorisation: 12/07/2004, Revision: 48, Status: Withdrawn

Human medicines European public assessment report (EPAR): Telzir, fosamprenavir, Date of authorisation: 12/07/2004, Revision: 48, Status: Withdrawn

Human medicines European public assessment report (EPAR): Granupas (previously Para-aminosalicylic acid Lucane), para-aminosalicylic acid, Date of authorisation: 07/04/2014, Revision: 13, Status: Withdrawn

Human medicines European public assessment report (EPAR): Granupas (previously Para-aminosalicylic acid Lucane), para-aminosalicylic acid, Date of authorisation: 07/04/2014, Revision: 13, Status: Withdrawn

Human medicines European public assessment report (EPAR): Xiliarx, vildagliptin, Date of authorisation: 19/11/2008, Revision: 25, Status: Authorised

Human medicines European public assessment report (EPAR): Xiliarx, vildagliptin, Date of authorisation: 19/11/2008, Revision: 25, Status: Authorised

Second webinar on new approach methodologies (NAMs) in ecotoxicology: Gill cell line assay for acute fish toxicity prediction, Online, from 28 January 2026, 14:00 (CET) to 28 January 2026, 15:30 (CET)

Second webinar on new approach methodologies (NAMs) in ecotoxicology: Gill cell line assay for acute fish toxicity prediction, Online, from 28 January 2026, 14:00 (CET) to 28 January 2026, 15:30 (CET)

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.